ReviewMycopathologia2014
Multi-resistant aspergillosis due to cryptic species.
Review in Mycopathologia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- Invasive pulmonary aspergillosis caused by a rare species ofJAC-antimicrobial resistance · 2026Article
- Therapeutic Failure in Invasive Fungal Infections: Beyond Antifungal Resistance-A Narrative Review.Journal of fungi (Basel, Switzerland) · 2026Review
- Nosocomial invasive Aspergillus calidoustus infection in a CAR-T cell-treated patient with concomitant Aspergillus fumigatus respiratory infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Identification ofJournal of clinical microbiology · 2026Article
- DecipheringMicrobiology spectrum · 2025Article
- Review
- Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?Expert review of molecular diagnostics · 2024Review
- Evaluation of the Activity of Triazoles Against Non-Open forum infectious diseases · 2024Article
- Evaluation of Primers OPF-01, P54, and 1253 to IdentifyPathogens (Basel, Switzerland) · 2024Article
- Streptomyces camelliae sp. nov., isolated from rhizosphere soil of Camellia oleifera Abel.Archives of microbiology · 2024Article
- Accelerating the understanding ofCurrent research in microbial sciences · 2024Review
- Invasive aspergillosis in adult patients in Australia and New Zealand: 2017-2020.The Lancet regional health. Western Pacific · 2023Article
- Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-Journal of fungi (Basel, Switzerland) · 2023Review
- Integrative Taxonomy Approach Reveals Cryptic Diversity within the Phoretic Pseudoscorpion GenusInsects · 2023Article
- Virulence capacity of differentFrontiers in immunology · 2023Article
- A Practical Workflow for the Identification of Aspergillus, Fusarium, Mucorales by MALDI-TOF MS: Database, Medium, and Incubation Optimization.Journal of clinical microbiology · 2022Article
- Novel Clinical and Laboratorial Challenges in Aspergillosis.Microorganisms · 2022Article
- Who IsFrontiers in veterinary science · 2021Article
- Aspergillosis, Avian Species and the One Health Perspective: The Possible Importance of Birds in Azole Resistance.Microorganisms · 2020Review
- Successful treatment of invasive aspergillosis caused byMedical mycology case reports · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reports of cryptic species causing aspergillosis in humans are increasing in the literature. Cryptic species are defined as those which are morphologically indistinguishable, although their identifications can be confirmed using molecular or other techniques which continue to become more widely available in the clinical setting. Antifungal resistance has often been noted in these cases, and indeed there does appear to be a higher prevalence of reduced susceptibility in cryptic species. Many of these observations are published as individual case reports or as a small component of larger data sets, making it challenging to review and compare the data fully. This review article seeks to describe the susceptibility trends and key learning outcomes of specific cases of infections caused by cryptic species, including Aspergillus alliaceus, Aspergillus calidoustus, Aspergillus felis, Aspergillus lentulus, Aspergillus tubingensis, Aspergillus viridinutans and Neosartorya pseudofischeri. These reports highlight the clinical need for full accurate identification and susceptibility testing to guide patient care.
Indexed as
Identifiers
24969615What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.